<?xml version="1.0" encoding="UTF-8"?>
<ref id="B153-pharmaceutics-12-00688">
 <label>153.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Hagler</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Smith-Norowitz</surname>
    <given-names>T.A.</given-names>
   </name>
   <name>
    <surname>Chice</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Wallner</surname>
    <given-names>S.R.</given-names>
   </name>
   <name>
    <surname>Viterbo</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Mueller</surname>
    <given-names>C.M.</given-names>
   </name>
   <name>
    <surname>Gross</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Nowakowski</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Schulze</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Zenilman</surname>
    <given-names>M.E.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Sophorolipids decrease IgE production in U266 cells by downregulation of BSAP (Pax5), TLR-2, STAT3 and IL-6</article-title>
  <source>J. Allergy Clin. Immun.</source>
  <year>2007</year>
  <volume>119</volume>
  <fpage>S263</fpage>
  <pub-id pub-id-type="doi">10.1016/j.jaci.2006.12.399</pub-id>
 </element-citation>
</ref>
